Literature DB >> 19680621

[Informed consent for patients on early recognition of prostate carcinoma is insufficient].

C Börgermann1, F vom Dorp, R Rossi, M Schenck, H-J Luboldt, H Rübben.   

Abstract

Men that undergo an early detection investigation should be informed of the advantages and disadvantages as well as of the therapeutic consequences. In this study the quality of information was checked using the state of scientific knowledge of the patients.An informative consultation was carried out before the early detection investigation using a clarification brochure and an examination by a urologist. A questionnaire was also filled out after the investigation. A total of 1,536 men were questioned. Although 47% of the men had previously undertaken a PSA at least once, only 55% knew their own test result. Subjectively 82% of men felt well informed. In contrast one-third did not know the significance of an increased PSA level. In the field of patient clarification for the early detection for prostate cancer there are considerable deficits but the information received was considered adequate by the participants. However, more than one-third did not understand the significance of the PSA level.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680621     DOI: 10.1007/s00120-009-2074-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  7 in total

1.  Dispositional optimism as a predictor of men's decision-related distress after localized prostate cancer.

Authors:  Suzanne K Steginga; Stefano Occhipinti
Journal:  Health Psychol       Date:  2006-03       Impact factor: 4.267

2.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

3.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

Review 4.  Update on screening for prostate cancer with prostate-specific antigen.

Authors:  Hans-Peter Schmid; Walter Riesen; Ladislav Prikler
Journal:  Crit Rev Oncol Hematol       Date:  2004-04       Impact factor: 6.312

5.  Psychological reactions in men screened for prostate cancer.

Authors:  O Gustafsson; T Theorell; U Norming; A Perski; M Ohström; C R Nyman
Journal:  Br J Urol       Date:  1995-05

6.  Facing a prostate cancer diagnosis: who is at risk for increased distress?

Authors:  Ruben E Perczek; Michael A Burke; Charles S Carver; Arnon Krongrad; Martha K Terris
Journal:  Cancer       Date:  2002-06-01       Impact factor: 6.860

7.  Short-term effects of population-based screening for prostate cancer on health-related quality of life.

Authors:  M L Essink-Bot; H J de Koning; H G Nijs; W J Kirkels; P J van der Maas; F H Schröder
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

  7 in total
  3 in total

1.  [How can early detection programs become a men's health topic? Survey of urology practices].

Authors:  M Mathers; R Reichel; U Nadig; S Roth
Journal:  Urologe A       Date:  2011-12       Impact factor: 0.639

2.  Willingness to participate in mammography screening: a randomized controlled questionnaire study of responses to two patient information leaflets with different factual content.

Authors:  Elisabeth Gummersbach; Jürgen in der Schmitten; Achim Mortsiefer; Heinz-Harald Abholz; Karl Wegscheider; Michael Pentzek
Journal:  Dtsch Arztebl Int       Date:  2015-01-30       Impact factor: 5.594

3.  Effects of different information brochures on women's decision-making regarding mammography screening: study protocol for a randomized controlled questionnaire study.

Authors:  Elisabeth Gummersbach; Jürgen in der Schmitten; Heinz-Harald Abholz; Karl Wegscheider; Michael Pentzek
Journal:  Trials       Date:  2013-10-01       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.